These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


330 related items for PubMed ID: 22139427

  • 1. Cucurmosin induces apoptosis of BxPC-3 human pancreatic cancer cells via inactivation of the EGFR signaling pathway.
    Zhang B, Huang H, Xie J, Xu C, Chen M, Wang C, Yang A, Yin Q.
    Oncol Rep; 2012 Mar; 27(3):891-7. PubMed ID: 22139427
    [Abstract] [Full Text] [Related]

  • 2. Cucurmosin induces the apoptosis of human pancreatic cancer CFPAC-1 cells by inactivating the PDGFR-β signalling pathway.
    Xie J, Wang C, Zhang B, Yang A, Yin Q, Huang H, Chen M.
    Pharmacol Rep; 2013 Mar; 65(3):682-8. PubMed ID: 23950591
    [Abstract] [Full Text] [Related]

  • 3. PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug.
    Wang C, Yang A, Zhang B, Yin Q, Huang H, Chen M, Xie J.
    Pancreas; 2014 Mar; 43(2):291-7. PubMed ID: 24518510
    [Abstract] [Full Text] [Related]

  • 4. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF, Zhang GD, Huang YQ, Diao Y.
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [Abstract] [Full Text] [Related]

  • 5. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J, Yuan Z, Sun Y, Bu Y, Li W, Fei Z.
    Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
    [Abstract] [Full Text] [Related]

  • 6. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway.
    Xu Q, Ma J, Lei J, Duan W, Sheng L, Chen X, Hu A, Wang Z, Wu Z, Wu E, Ma Q, Li X.
    Biomed Res Int; 2014 Dec; 2014():546353. PubMed ID: 24812621
    [Abstract] [Full Text] [Related]

  • 7. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X, Hui Y, Hua Y, Huang L, Wang L, Peng F, Tang C, Liu D, Song J, Wang F.
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [Abstract] [Full Text] [Related]

  • 8. Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.
    Zheng YT, Yang HY, Li T, Zhao B, Shao TF, Xiang XQ, Cai WM.
    Acta Pharmacol Sin; 2015 May; 36(5):614-26. PubMed ID: 25864651
    [Abstract] [Full Text] [Related]

  • 9. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway.
    Li B, Yang J, Lu Z, Liu B, Liu F.
    J BUON; 2019 May; 24(2):739-745. PubMed ID: 31128031
    [Abstract] [Full Text] [Related]

  • 10. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.
    Liu S, Wang XJ, Liu Y, Cui YF.
    Am J Chin Med; 2013 May; 41(3):629-42. PubMed ID: 23711146
    [Abstract] [Full Text] [Related]

  • 11. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH, Xue A, Julovi SM, Pavlakis N, Samra JS, Hugh TJ, Gill AJ, Peters L, Baxter RC, Smith RC.
    Clin Cancer Res; 2014 Aug 01; 20(15):4047-58. PubMed ID: 24895459
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells.
    Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH.
    Mol Cancer Ther; 2006 Mar 01; 5(3):483-93. PubMed ID: 16546962
    [Abstract] [Full Text] [Related]

  • 13. Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway.
    Zheng J, Hu JD, Chen YY, Chen BY, Huang Y, Zheng ZH, Liu TB.
    Asian Pac J Cancer Prev; 2012 Mar 01; 13(4):1119-24. PubMed ID: 22799292
    [Abstract] [Full Text] [Related]

  • 14. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N, Nanta R, Sharma J, Gunewardena S, Singh KP, Shankar S, Srivastava RK.
    Oncotarget; 2015 Oct 13; 6(31):32039-60. PubMed ID: 26451606
    [Abstract] [Full Text] [Related]

  • 15. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z, Li C, Xi H, Gao Y, Xu D.
    Mol Med Rep; 2015 Oct 13; 12(4):5415-22. PubMed ID: 26166196
    [Abstract] [Full Text] [Related]

  • 16. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR, Chen JM, Zeng ZY, Que WZ.
    J Int Med Res; 2013 Jun 13; 41(3):584-95. PubMed ID: 23613505
    [Abstract] [Full Text] [Related]

  • 17. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y, Xi L, Li Q, Cai Z, Lai Y, Zhang X, Yu C.
    Oncol Rep; 2016 Jul 13; 36(1):49-56. PubMed ID: 27220401
    [Abstract] [Full Text] [Related]

  • 18. Oxymatrine induces cell cycle arrest and apoptosis and suppresses the invasion of human glioblastoma cells through the EGFR/PI3K/Akt/mTOR signaling pathway and STAT3.
    Dai Z, Wang L, Wang X, Zhao B, Zhao W, Bhardwaj SS, Ye J, Yin Z, Zhang J, Zhao S.
    Oncol Rep; 2018 Aug 13; 40(2):867-876. PubMed ID: 29989652
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
    Boreddy SR, Pramanik KC, Srivastava SK.
    Clin Cancer Res; 2011 Apr 01; 17(7):1784-95. PubMed ID: 21350002
    [Abstract] [Full Text] [Related]

  • 20. Influence of carboplatin on the proliferation and apoptosis of ovarian cancer cells through mTOR/p70s6k signaling pathway.
    Zhou H, Zhao H, Liu H, Xu X, Dong X, Zhao E.
    J BUON; 2018 Apr 01; 23(6):1732-1738. PubMed ID: 30610801
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.